Jyong Biotech Ltd. (Revived IPO) MENS 深 沪
交易中 11-21 10:07:41 美东时间
33.77
+0.970
+2.96%
华盛通- 最 高33.77
- 今 开32.80
- 成交量 5609股
- 最 低 31.91
- 昨 收 32.80
- 总市值 25.67亿
- 52周最高 67.00
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 6.0101
- 委 比 -22.58%
- 总股本 7602.77万
- 历史最高 67.00
- 量 比 0.25
- 振 幅 5.67%
- 历史最低 6.0101
- 每 手 1
- 风险率 19.25%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Jyong Biotech Completes Statistical Analysis Of Primary Efficacy Endpoints In Ongoing Phase II Clinical Trial Of MCS-8 Conducted In Taiwan
Jyong Biotech Ltd. (NASDAQ:MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative and differentiated new drugs
11-20 21:38
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers MSP Recovery (NASDAQ:MSPR) stock increased by 36.4% to $0.3 during Fri...
11-01 05:07
美股牛股 | 多只绩优股大涨！福斯涨超30%、泰瑞达大涨超20%
多只绩优股大涨！福斯涨超30%，公司上调2025年美股每股收益指引至3.40-3.50美元；泰瑞达大涨超20%，预计Q4收入9.2亿至10亿美元>>
10-30 15:33
Caterpillar Posts Upbeat Q3 Results, Joins United Therapeutics, Centene, Fortive And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were higher, with the Dow Jones index gaining around 200 points on ...
10-29 22:46
美股周涨跌榜 | “氢能第一股”再度爆发！普拉格能源周涨超60%；Lithium Americas周涨超42%
“氢能第一股”再度爆发！普拉格能源周涨超60%，已连涨四周；Lithium Americas周涨超42%，获美国能源部入股；TSHA周涨超46%，试验性治疗获FDA突破性疗法认定>>
10-06 15:15
Jyong Biotech Wins Innovation Gold Award in Pharmaceutical Category at 2025 Taipei Biotech Awards
Jyong Biotech Ltd., a Taiwan-based biotech company specializing in plant-derived drugs for urinary system diseases, announced its subsidiary, Health Ever Bio-Tech Co., Ltd., won the 2025 Taipei Biotech Awards Innovation Gold Award for BOTRESO®. This oral plant-derived investigational new drug for treating benign prostatic hyperplasia (BPH) and lower urinary tract syndrome (LUTS), holds multiple patents and has completed four Phase III clinical tr...
09-29 12:30
Jyong Biotech Chairwoman and CEO Set to Attend as Speaker at 2025 Global Business Forum in Taipei
New Taipei City, Taiwan, September 18, 2025 – Jyong Biotech Ltd. announced that its chairwoman and CEO, Fu Feng Kuo, will speak at the 2025 Global Business Forum on September 19. The event, organized by the Taiwanese Chambers of Commerce of North America, aims to facilitate US-Taiwan biotech collaboration. Kuo will discuss aligning Taiwan's biotech and medical industries with global trends. The forum will focus on innovative drug development, cro...
09-18 12:30
Jyong Biotech Announces Completion of Patient Enrollment of over 700 subjects in Phase II Clinical Trial of MCS‑8 for Prostate Cancer Prevention
Jyong Biotech Ltd., a Taiwanese biotechnology company focused on developing plant-derived drugs for urinary system diseases, has successfully completed patient enrollment in its Phase II clinical trial for MCS-8, an investigational prostate cancer prevention drug, with over 700 high-risk participants recruited across 20 hospitals in Taiwan. The trial, conducted during the COVID-19 pandemic, has exceeded expectations, highlighting the company's pr...
09-16 12:18
Jyong Biotech Ltd. Participated in the 22nd Urological Association of Asia Congress to Display the Clinical Data for its Phase III Studies of BOTRESO and Phase II Study of MCS-8 (PCP)
Jyong Biotech Ltd., a Taiwanese biotech company, presented results from Phase III clinical trials of BOTRESO® for benign prostatic hyperplasia (BPH) at the 22nd Urological Association of Asia Congress. The trials showed significant improvement in lower urinary tract symptoms in Asian and Taiwanese subgroups, with long-term safety confirmed. BOTRESO® is the first Taiwanese-developed oral botanical drug to reach Phase III in the U.S. The company al...
08-22 13:00
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Equillium (NASDAQ:EQ) shares moved upwards by 98.9% to $0.98 during Mo...
08-12 01:06
